Docetaxel trihydrate

• Target :

  Microtubule Associated|||Bcl-2 Family|||Apoptosis

• Related Pathways :

  Cytoskeletal Signaling|||Apoptosis

• Purity :

  >99.99%

• Bioactivity :

  Docetaxel trihydrate (RP-56976 Trihydrate) is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis and that currently plays a central role in the therapy of many solid tumor including breast and lung cancer. Therapy with docetaxel has been associated with a low rate of serum enzyme elevations and rarely to instances of acute hepatic necrosis generally due to severe hypersensitivity reactions or sepsis.

• Smiles :

  O.O.O.CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)C(O)C(NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C

• Molecular Formula :

  C43H59NO17

• Molecular Weight :

  861.95

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  148408-66-6